Posted by admin on March 31st, 2009 in Cholesterol
Data from a new study showed that Abbott’s TRILIPIX(R) (fenofibric acid) delayed-release capsules in combination with rosuvastatin calcium met all of the study’s primary endpoints. TRILIPIX 135 mg in combination with rosuvastatin calcium 5 mg significantly improved HDL cholesterol and triglycerides compared to rosuvastatin calcium 5 mg alone, and significantly improved LDL cholesterol compared to [...]
Posted by admin on March 31st, 2009 in Diabetes
UroToday.com – In the online version of The Prostate, a group of Korean investigators linked pre-radical prostatectomy (RP) hemoglobin A1c (HbA1c) levels in patients with type II diabetes mellitus (DM) and tumor aggressiveness. The retrospective study analyzed the records of 740 men with prostate cancer (CaP) who underwent RP for clinically localized disease. [...]
Posted by admin on March 31st, 2009 in Diabetes
Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naïve type 2 diabetes patients, compared to placebo.
Posted by admin on March 31st, 2009 in Medical News
AP – Bill Darker grinned as he headed into the operating room for a dramatic experiment: A super-high dose of chemotherapy dripped directly into his cancer-ridden liver, 10 times more than patients normally can tolerate. Not to fear. Working through small puncture holes, doctors sealed off Darker’s liver and washed most of the toxic medication [...]
Posted by admin on March 31st, 2009 in Medical News
AP – Federal food safety officials warned Monday that consumers should stop eating all foods containing pistachios while they figure out the source of a possible salmonella contamination.
Posted by admin on March 31st, 2009 in Medical News
AP – It’s been a dream for a decade: a single daily pill combining aspirin, cholesterol medicine and blood pressure drugs everything people need to prevent heart attacks and strokes in a cheap, generic form.
Posted by admin on March 31st, 2009 in Medical Devices
New data released at the 2009 American College of Cardiology meeting demonstrated exceptional long-term safety and effectiveness results for the Endeavor drug-eluting coronary stent from Medtronic, Inc. (NYSE:MDT), in a large multicenter, real-world study, in which no defined patient selection criteria were specified, and angioplasty was used at medical discretion.
Posted by admin on March 31st, 2009 in Medical Devices
Removing thrombus from coronary arteries with the Export Aspiration Catheter from Medtronic, Inc. (NYSE:MDT), before implanting a stent in patients suffering a specific kind of heart attack, “results in excellent clinical outcomes,” at one year, according to new data released today at the American College of Cardiology (ACC) meeting.
Posted by admin on March 30th, 2009 in Psychology
A US study that tracked eye movements of autistic and non-autistic toddlers watching animations found that autistic toddlers tended to pay more attention to those movements that coincided with sound rather than any other, giving a possible explanation for why autistic young children stare more at people’s [...]
Posted by admin on March 30th, 2009 in Psychology
There is no evidence that desvenlafaxine (Pristiq) is more effective, safer or better tolerated than its parent drug, venlafaxine, or other antidepressants, NPS advises in the latest edition of NPS RADAR. Desvenlafaxine was recently listed on the PBS for major depressive disorder. It is the active metabolite of venlafaxine but [...]
